Skip to main content
. 2022 Jul 5;23:178. doi: 10.1186/s12931-022-02095-6

Fig. 3.

Fig. 3

Change from baseline in FVC (mL) at week 52 in subjects in the SENSCIS trial versus matched hypothetical healthy references in subgroups by mycophenolate use at baseline. Reference subjects were matched to the SENSCIS subjects for age, sex, ethnicity and height